76 related articles for article (PubMed ID: 8822210)
1. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
2. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P
J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines.
Nakamura Y; Matsubara D; Goto A; Ota S; Sachiko O; Ishikawa S; Aburatani H; Miyazawa K; Fukayama M; Niki T
Cancer Sci; 2008 Jan; 99(1):14-22. PubMed ID: 17953713
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
5. Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility.
Cutrupi S; Baldanzi G; Gramaglia D; Maffè A; Schaap D; Giraudo E; van Blitterswijk W; Bussolino F; Comoglio PM; Graziani A
EMBO J; 2000 Sep; 19(17):4614-22. PubMed ID: 10970854
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
Mungunsukh O; McCart EA; Day RM
Biomedicines; 2014 Nov; 2(4):301-326. PubMed ID: 28548073
[TBL] [Abstract][Full Text] [Related]
7. cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.
Van Der Steen N; Pauwels P; Gil-Bazo I; Castañon E; Raez L; Cappuzzo F; Rolfo C
Cancers (Basel); 2015 Mar; 7(2):556-73. PubMed ID: 25815459
[TBL] [Abstract][Full Text] [Related]
8. Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.
Lee JK; Joo KM; Lee J; Yoon Y; Nam DH
Onco Targets Ther; 2014; 7():1933-44. PubMed ID: 25364264
[TBL] [Abstract][Full Text] [Related]
9. Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy.
Bhardwaj V; Cascone T; Cortez MA; Amini A; Evans J; Komaki RU; Heymach JV; Welsh JW
Cancer; 2013 May; 119(10):1768-75. PubMed ID: 23423860
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607.
Dai Y; Siemann DW
BMC Cancer; 2012 May; 12():198. PubMed ID: 22639908
[TBL] [Abstract][Full Text] [Related]
11. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.
Mak H; Naba A; Varma S; Schick C; Day A; SenGupta SK; Arpin M; Elliott BE
BMC Cancer; 2012 Mar; 12():82. PubMed ID: 22397367
[TBL] [Abstract][Full Text] [Related]
12. An overview of the c-MET signaling pathway.
Organ SL; Tsao MS
Ther Adv Med Oncol; 2011 Nov; 3(1 Suppl):S7-S19. PubMed ID: 22128289
[TBL] [Abstract][Full Text] [Related]
13. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
You WK; McDonald DM
BMB Rep; 2008 Dec; 41(12):833-9. PubMed ID: 19123972
[TBL] [Abstract][Full Text] [Related]
14. Blockade of endogenous reactive oxygen species by N-acetyl-L-cysteine suppresses the invasive activity of rat hepatoma cells by modulating the expression of hepatocyte growth factor gene.
Miura Y; Tsukamoto S; Yagasaki K
Cytotechnology; 2003 Nov; 43(1-3):121-6. PubMed ID: 19003216
[TBL] [Abstract][Full Text] [Related]
15. Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.
Christophi C; Harun N; Fifis T
J Gastrointest Surg; 2008 May; 12(5):966-80. PubMed ID: 18181006
[TBL] [Abstract][Full Text] [Related]
16. Role of cancer cell-stroma interaction in invasive growth of cancer cells.
Kataoka H; Tanaka H; Nagaike K; Uchiyama S; Itoh H
Hum Cell; 2003 Mar; 16(1):1-14. PubMed ID: 12971620
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.
Herynk MH; Tsan R; Radinsky R; Gallick GE
Clin Exp Metastasis; 2003; 20(4):291-300. PubMed ID: 12856716
[TBL] [Abstract][Full Text] [Related]
18. GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase.
Popsueva A; Poteryaev D; Arighi E; Meng X; Angers-Loustau A; Kaplan D; Saarma M; Sariola H
J Cell Biol; 2003 Apr; 161(1):119-29. PubMed ID: 12682085
[TBL] [Abstract][Full Text] [Related]
19. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
[TBL] [Abstract][Full Text] [Related]
20. Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.
Soriano JV; Pepper MS; Orci L; Montesano R
J Mammary Gland Biol Neoplasia; 1998 Apr; 3(2):133-50. PubMed ID: 10819523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
